Results 191 to 200 of about 2,226,679 (338)

Field‐applicable low‐intensity exercise induces bronchodilation in horses with severe asthma

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Airway dysfunction in severe equine asthma (SEA) often results in early retirement or euthanasia of affected horses. Exercise‐induced bronchodilation occurs in horses with SEA after intense treadmill exercise, but the effects of a lighter, field‐applicable, training regimen remain largely unexplored.
Sophie Mainguy‐Seers   +2 more
wiley   +1 more source

Polylysine as histamine releaser

open access: yesJournal of Pharmacy and Pharmacology, 1968
openaire   +2 more sources

First successful protocol for desensitization to eptinezumab

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Eptinezumab is an anti‐calcitonin gene‐related peptide monoclonal antibody used for migraine prevention. During clinical trials, hypersensitivity to eptinezumab was described without a clear underlying mechanism. To determine if the reaction was immunoglobulin E–mediated, the team of Nice University Hospital (Nice, France) performed
Benoit Gerard   +8 more
wiley   +1 more source

Histamine release from mast cells

open access: diamond, 1991
Mitsunobu Mio, Kenjí Tasaka
openalex   +1 more source

Cutaneous Immune‐Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Introduction Immune checkpoint inhibitors (ICIs) have significantly improved outcomes for patients with advanced solid tumors. While low‐grade immune‐related adverse events (irAEs) are associated with prolonged survival, high‐grade irAEs have been associated with poorer survival. Cutaneous immune‐related adverse events (cirAEs) affect up to 20%
David O'Reilly   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy